S. Koletar

发表

Long-term body composition changes in antiretroviral-treated HIV-infected individuals

A. Collier, D. Kitch, T. Brown, 2016, AIDS.

Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers

A. Ferketich, S. Koletar, P. Diaz, 2016, AIDS and Behavior.

Bacteremia With Streptococcus pneumoniae: Implications for Therapy and Prevention

J. R. Parsons, S. Koletar, R. Breiman, 1996 .

No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial

R. Lorenzo-Redondo, C. Fichtenbaum, P. Sax, 2019, Open forum infectious diseases.

Third-Trimester Maternal Toxicity With Nevirapine Use in Pregnancy

S. Koletar, M. Poi, M. Brady, 2005, Obstetrics and gynecology.

Comparison of Cardiovascular Disease Risk Markers in HIV-Infected Patients Receiving Abacavir and Tenofovir: The Nucleoside Inflammation, Coagulation and Endothelial Function (Nice) Study

C. Fichtenbaum, P. Sax, B. Taiwo, 2014, Antiviral therapy.

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

L. Szczech, S. Koletar, Samir K. Gupta, 2008, AIDS.

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

J. Currier, S. Koletar, H. Valdez, 2000, Annals of internal medicine.

Skin Test Reactivity and Cellular Immune Responses toMycobacterium avium Sensitin in AIDS Patients at Risk for Disseminated M. avium Infection

C. F. von Reyn, J. Currier, S. Koletar, 2001, Clinical Diagnostic Laboratory Immunology.

Reply to Phillips

J. Currier, S. Koletar, R. Murphy, 2005 .

Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.

D. Peterson, L. Picker, L. Bermudez, 2005, AIDS research and human retroviruses.

Treatment of Mycobacterium avium in Human Immunodeficiency Virus-Infected Individuals

S. Koletar, 1997 .

A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

H. Waskin, S. Spector, D. Finkelstein, 1995 .

Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.

K. Yarasheski, A. Zolopa, S. Koletar, 2008, The American journal of clinical nutrition.

Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity

W. Sadee, S. Koletar, Danxin Wang, 2011, Pharmacogenetics and genomics.

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

S. Koletar, J. Plouffe, R. Fass, 1990, Antimicrobial Agents and Chemotherapy.

Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis

A. Collier, D. Jacobson, S. Koletar, 2011, Oncology.

Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients

A. Papp, S. Koletar, Danxin Wang, 2012, BMC Medical Genomics.

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults

T. Harrer, D. Podzamczer, C. Katlama, 2016, Medicine.

Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir

A. Zolopa, D. Haas, E. Acosta, 2009, Journal of acquired immune deficiency syndromes.

Effect of Concomitantly Administered Rifampin on the Pharmacokinetics and Safety of Atazanavir Administered Twice Daily

A. Zolopa, D. Haas, E. Acosta, 2007, Antimicrobial Agents and Chemotherapy.

Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV

F. Palella, S. Koletar, K. Erlandson, 2021, Journal of Acquired Immune Deficiency Syndromes.

Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.

S. Koletar, K. Stevenson, J. Mangino, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

R. Parker, R. Fielding, S. Koletar, 2007, AIDS.

Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1A Randomized, Controlled Equivalence TrialNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1

D. Kuritzkes, C. Fichtenbaum, D. Haas, 2014 .

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.

A. Collier, D. Kitch, T. Brown, 2016, The Journal of infectious diseases.

Intraorbital Injection of Amphotericin B for Palliative Treatment of Aspergillus Orbital Abscess

S. Koletar, K. Cahill, C. Hogan, 1994, Ophthalmic plastic and reconstructive surgery.

Safety reporting in clinical trials.

S. Koletar, J. Neidig, 2001, JAMA.

Proteinuria, CrCl, and Immune Activation in Antiretroviral-Naïve HIV-Infected Subjects

L. Szczech, S. Koletar, Samir K. Gupta, 2010 .

Screening and Enrollment by Sex in HIV Clinical Trials in the United States.

A. Collier, S. Koletar, L. Smeaton, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Exposure of Leukocytes to HIV Preexposure Prophylaxis Decreases Mitochondrial Function and Alters Gene Expression Profiles

M. Lederman, M. Cameron, S. Koletar, 2020, Antimicrobial Agents and Chemotherapy.

Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV).

R. Ellis, F. Palella, N. Sacktor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.

S. Koletar, D. Goff, R. Fass, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Absence of Sustained Hyperlactatemia in HIV-Infected Patients With Risk Factors for Mitochondrial Toxicity

S. Evans, G. McComsey, S. Koletar, 2004, Journal of acquired immune deficiency syndromes.

Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients.

S. Koletar, P. A. Murray, B. Moskovitz, 1997, Clinical therapeutics.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to Vascular Inflammation in Human Immunodeficiency Virus Infection

M. Lederman, S. Koletar, A. Turner, 2016, Open forum infectious diseases.

Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.

G. Robbins, L. Szczech, N. Franceschini, 2009, The Journal of infectious diseases.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.

F. Palella, B. Taiwo, S. Koletar, 2017, AIDS (London).

Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral TherapyInduced Increases in CD4+ Cell Count

Paige L. Williams, J. Currier, S. Koletar, 2000, Annals of Internal Medicine.

Exposure to domestic cats: risk factor for Pasteurella multocida peritonitis in liver cirrhosis?

S. Koletar, C. A. Koch, C. Mabee, 1996, The American journal of gastroenterology.

Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.

S. Koletar, P. Sundstrom, C. Allen, 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Plasma Citrate and Succinate Are Associated with Neurocognitive Impairment in Older People with HIV.

R. Ellis, F. Palella, C. Hoppel, 2021, Clinical Infectious Diseases.

Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.

C. Yiannoutsos, C. Fichtenbaum, M. Saag, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

M. Saag, K. Squires, D. Bamberger, 1997, The American journal of medicine.

Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.

C. Yiannoutsos, C. Fichtenbaum, D. Skiest, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cluster of Histoplasmosis Cases in Prisoners with HIV Infection

S. Koletar, M. Para, R. Fass, 1995 .

Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy.

J. Currier, S. Koletar, R. Murphy, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy

Richard D Moore, Patrick A Ryscavage, B. Taiwo, 2013, AIDS.

Cirrhosis: a risk factor for cryptococcal peritonitis.

S. Koletar, R. Kirkpatrick, C. Mabee, 1995, The American journal of gastroenterology.

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

H. Waskin, D. Finkelstein, S. Koletar, 1995, The New England journal of medicine.

Varicella-zoster retinitis in human immunodeficiency virus infection. Case report.

S. Koletar, F. Davidorf, R. Derick, 1989, Archives of ophthalmology.

Infections of the Central Nervous System Due to Nutritionally Variant Streptococci: Report of 4 Cases and Review of the Literature

S. Koletar, J. Bazan, R. Bakker, 2012 .

Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial

C. Fichtenbaum, P. Sax, E. Acosta, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virologic and Serologic Outcomes of Mono Versus Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort

Minhee Kang, S. Koletar, J. Aberg, 2014, Journal of acquired immune deficiency syndromes.

Cigarette smoking in the HIV-infected population.

A. Ferketich, S. Koletar, P. Diaz, 2011, Proceedings of the American Thoracic Society.

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Christopher D Pilcher, Edward P Acosta, Daniel R Kuritzkes, 2006, JAMA.

AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline Characteristics

R. Bosch, A. Collier, S. Koletar, 2008, HIV clinical trials.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

David W. Haas, Todd T. Brown, Daniel R. Kuritzkes, 2014, Annals of internal medicine.

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Lynne Peeples, David Katzenstein, Victoria A Johnson, 2009, The New England journal of medicine.

Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin

K. Dooley, J. Park, D. Haas, 2014, Antimicrobial Agents and Chemotherapy.

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study

Yang Liu, S. Koletar, J. Lake, 2022, The Lancet Infectious Diseases.

Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection

R. Ellis, F. Palella, B. Taiwo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term impact of HIV wasting on physical function

J. Margolick, F. Palella, T. Brown, 2015, AIDS.

Relationship Between CD4+ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials Study

R. Bosch, A. Collier, S. Koletar, 2010, Journal of acquired immune deficiency syndromes.

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

Michael J. Taylor, R. Heaton, R. Ellis, 2007, AIDS.

Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected Persons

M. Lederman, M. Cameron, S. Koletar, 2019, Front. Immunol..

Safety of varenicline among smokers enrolled in the lung HIV study.

Bo Lu, A. Ferketich, S. Koletar, 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Association of Fibroblast Growth Factor-23 (FGF-23) With Incident Frailty in HIV-Infected and HIV-Uninfected Individuals

F. Palella, M. Shlipak, J. Ix, 2019, Journal of acquired immune deficiency syndromes.

Effect of HIV-infection and cumulative viral load on age-related decline in grip strength

J. Margolick, J. Phair, J. Schrack, 2016, AIDS.

Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men

L. Ferrucci, J. Margolick, J. Phair, 2015, Journal of acquired immune deficiency syndromes.

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.

N. Roberts, J. McCutchan, M. McElrath, 2003, The Journal of infectious diseases.

Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.

J. Currier, S. Koletar, J. Aberg, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus

R. Ellis, F. Palella, K. Robertson, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4+ T cells.

H. Lane, S. Koletar, C. Yoshizawa, 2003, Clinical immunology.

Azithromycin as Treatment for DisseminatedMycobacterium avium Complex in AIDS Patients

J. Currier, S. Koletar, M. Cynamon, 1999, Antimicrobial Agents and Chemotherapy.

A Collaborative Intervention Between Emergency Medicine and Infectious Diseases to Increase Syphilis and HIV Screening in the Emergency Department

S. Koletar, J. Bazan, M. Lustberg, 2021, Sexually transmitted diseases.

Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362

K. Robertson, J. Currier, S. Koletar, 2011, AIDS care.

Regional Differences in Risk of Recurrent Falls Among Older U.S. Women and Men with HIV in the HIV infection, Aging, and Immune Function Long-Term Observational Study (HAILO).

T. Brown, S. Koletar, M. Yin, 2022, AIDS research and human retroviruses.

Incidence Rate of and Factors Associated with Loss to Follow-up in a Longitudinal Cohort of Antiretroviral-Treated HIV-Infected Persons: An AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Analysis

R. Bosch, A. Collier, S. Koletar, 2011, HIV clinical trials.

HIV and asthma, is there an association?

S. Koletar, P. Diaz, Jonathan P. Parsons, 2012, Respiratory medicine.

Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection

J. Phair, C. Thio, M. Witt, 2016, Journal of acquired immune deficiency syndromes.

Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease and diabetes among aging adults with HIV.

F. Palella, S. Koletar, K. Tassiopoulos, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Frailty and Circulating Markers of Inflammation in HIV+ and HIV− Men in the Multicenter AIDS Cohort Study

J. Margolick, J. Phair, S. Koletar, 2017, Journal of acquired immune deficiency syndromes.

Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS).

J. Margolick, M. Budoff, E. Guallar, 2018, Journal of cardiovascular computed tomography.

Macrophage maturation from blood monocytes is altered in people with HIV, and is linked to serum lipid profiles and activation indices: A model for studying atherogenic mechanisms

M. Lederman, S. Raman, M. Cameron, 2020, PLoS pathogens.

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l

J. McCutchan, D. Finkelstein, J. Currier, 2001, AIDS.

HIV Infection Is Associated with Increased Fatty Infiltration of the Thigh Muscle with Aging Independent of Fat Distribution

J. Margolick, W. Post, F. Palella, 2017, PloS one.

Detrimental Effects of Psychotropic Medications Differ by Sex in Aging People with HIV

K. Goodkin, S. Koletar, S. Mathur, 2019, Journal of acquired immune deficiency syndromes.

No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.

J. Lok, R. Bosch, A. Collier, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression

D. Kuritzkes, K. Squires, B. Schackman, 2007, AIDS.

Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients

A. Papp, S. Koletar, Danxin Wang, 2012, BMC Medical Genomics.

The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection

J. Lok, K. Robertson, D. Kitch, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients

S. Koletar, M. Glesby, D. Chow, 2009, AIDS.

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART

A. Perelson, R. Koup, J. Casazza, 2018, Open forum infectious diseases.

Association between metformin use and cognitive and physical function in persons with HIV and diabetes.

F. Palella, S. Letendre, T. Brown, 2023, AIDS research and human retroviruses.

Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy

R. Ellis, F. Palella, B. Taiwo, 2017, The Journal of infectious diseases.

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

Michael T. Lu, C. Fichtenbaum, P. Douglas, 2021, JAMA network open.

Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults: a prospective cohort study.

F. Palella, B. Taiwo, S. Koletar, 2017, AIDS.

Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV

A. Adimora, F. Palella, M. Witt, 2023, AIDS.

Baseline neurocognitive impairment (NCI) is associated with incident frailty but baseline frailty does not predict incident NCI in older persons with HIV.

R. Ellis, F. Palella, N. Sacktor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improved Survival and Reduced Clinical Progression in HIV-Infected Patients with Advanced Disease Treated with Saquinavir plus Zalcitabine

R. Haubrich, D. Richman, H. Burger, 1998, Antiviral Therapy.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study

C. Fichtenbaum, S. Koletar, C. Roberts-Toler, 2020, Journal of medical Internet research.

Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.

D. Kuritzkes, K. Squires, C. Shikuma, 2007, The Journal of infectious diseases.

Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study (Preprint)

C. Fichtenbaum, S. Koletar, C. Roberts-Toler, 2020 .

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

L. Szczech, S. Koletar, Samir K. Gupta, 2008, AIDS.

Topography of cerebellar corticonuclear fibers of the albino rat. Vermis of anterior and posterior lobes.

D. Haines, S. Koletar, 1979, Brain, behavior and evolution.

Brief report: Circulating markers of fibrosis are associated with immune reconstitution status in HIV-infected men

F. Palella, T. Brown, S. Koletar, 2018, PloS one.

Risk of COVID-19 after natural infection or vaccination

Nicole L. Nollen, Eric A. Meyerowitz, Waseem M. Chughtai, 2023, EBioMedicine.

A. Adimora, K. Anastos, F. Palella, 2023, JAMA network open.